ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 350c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of $3.50. Revenue for the quarter came in at $98.15 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Samsung Plans As Much As $79 Billion In Shareholder Returns - Bloomberg
• Largo restructures $82.2M in debt, extending maturity to 2030